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Abstract
Background: Resistance and susceptibility to scrapie has been associated with single nucleotide
polymorphisms located within codons 136, 154 and 171 of the ovine prion protein gene (PRNP).
Dual-labelled HyBeacon probes were developed to analyse single and clustered polymorphisms
within these and neighbouring codons.
Methods:  Extracted DNAs and unpurified blood samples were genotyped with respect to
polymorphisms in PRNP codons 136, 141, 154 and 171. PCR amplicons were investigated using a
LightTyper instrument, measuring the stability of probe/target hybridisation through peak melting
temperatures and determining the sequence of nucleotides at polymorphic sites.
Results: The performance of HyBeacon assays was evaluated in a validation study comparing
genotypes with those obtained using a primer extension assay (Sequenom MassEXTEND) analysed
on a MALDI-ToF mass spectrometer. Over 12,000 sheep samples were successfully genotyped,
reliably detecting A136, V136, T136, T137, L141, F141 R154, H154, L168, R171, Q171, H171 and K171 sequence
variants using only 4 HyBeacon probes.
Conclusion: HyBeacon assays provide an extremely robust and accurate method for the analysis
of single and clustered PRNP polymorphisms in a high-throughput format. The flexibility of the
diagnostic tests ensures that samples are correctly genotyped even in the presence of additional
sequence variations that flank the polymorphisms of interest. Such sequence variations may also be
neutralised using universal bases such as 5-nitroindole if required.
Background
Scrapie, one of several transmissible spongiform enceph-
alopathies (TSEs), is a neurodegenerative and fatal disease
that affects sheep and goats. Scrapie is infectious and
thought to be transmissible between animals via an iso-
form of the prion protein (PrPsc) [1]. The cellular prion
protein (PrPc) is 256 amino acids in length and is encoded
by the host prion protein gene (PRNP). Resistance and
susceptibility to scrapie has been associated with single
nucleotide polymorphisms (SNPs) affecting the amino
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acids specified by codons 136, 154 and 171 of the PRNP
gene [2,3]. Five common alleles have been identified,
commonly referred to by the single letter amino acid
codes for these three codons (i.e. ARR, ARQ, VRQ, AHQ
and ARH) [4]. TRQ and ARK alleles have also been
described, arising from additional SNPs in codons 136
and 171 respectively [5,6]. Certain prion protein geno-
types confer resistance to scrapie and selective breeding
programmes have sought to increase the number of sheep
that are genetically resistant and eventually eradicate the
disease from sheep flocks [7] particularly via national
screening programmes within Europe. In addition to clas-
sical scrapie, cases of atypical scrapie have recently been
identified and linked to a polymorphism within codon
141 [8,9]. Genotypes such as ARR/ARR that are consid-
ered to be genetically resistant to classical scrapie appear
to be susceptible to atypical scrapie infection [10-12].
Direct sequencing accurately genotypes samples with
respect to SNPs in codons 136, 154 and 171 and will reli-
ably identify any additional polymorphisms in neigh-
bouring codons. However, genotyping technologies such
as sequencing and restriction fragment length polymor-
phism (RFLP) analysis do not lend themselves to high-
throughput analysis of large numbers of samples. High-
throughput genotyping technologies benefit significantly
from automated methods involving robotics and LIMS
(laboratory information management systems) to track
samples throughout the process. The analysis of large
numbers of ovine samples has been performed using tech-
niques such as fluorescent primer extension [13,14],
ARMS (amplification refractory mutation system) [15]
and MALDI-ToF (matrix assisted laser desorption ionisa-
tion time of flight) mass spectrometry [16]. Such technol-
ogies require multiple technical steps that are both time-
consuming and costly. In contrast, homogeneous assays
are performed in a single tube and typically reduce hands-
on time and thereby the overall cost of the test. Homoge-
neous detection technologies frequently utilise the
sequence specific hybridisation of fluorescent oligonucle-
otides and an associated property, such as the exonuclease
dependent degradation of hydrolysis probes (also known
as TaqMan), to monitor the real-time amplification of
specific DNA sequences. Variations in probe hybridisa-
tion stability are exploited to differentiate closely related
target sequences, such as PRNP polymorphisms [17].
Additional nucleotide polymorphisms have been identi-
fied in codons neighbouring 136, 154 and 171, with
sheep possessing alleles such as AT137RQ, AR143RQ,
AC151RQ, ARL168Q and ARQE175 [18]. Whilst these haplo-
types are relatively rare, the additional polymorphisms
may compromise PRNP genotyping using primer exten-
sion and real-time PCR technologies since they will desta-
bilise the hybridisation process and potentially cause
miscalls.
We have developed homogeneous high-throughput diag-
nostic tests, employing the fluorescent HyBeacon® probe
technology [19,20], to reliably genotype sheep with
respect to polymorphisms within codons 136, 154 and
171 polymorphisms in a background of neighbouring
and potentially interfering SNPs and mutations. Analysis
of the leucine/phenylalanine polymorphism within
codon 141 [9] is also described.
Probes are included in PCR assays and emit greater
amounts of fluorescence when hybridised to complemen-
tary target sequences than when single-stranded. Follow-
ing amplification, the presence and identity of target
sequences is determined by melting curve analysis. Dual-
labelled probes, possessing two fluorescent dye labels
attached to internal nucleotides, exhibit considerably
larger signal-to-noise ratios and melting peaks compared
with single-labelled probes of identical sequence [21]. The
stability and melting temperature of hybridised probes
depends on the degree of homology between HyBeacons
and their target sequences. Increasing the reaction temper-
ature above the melting temperature (Tm) of the HyBea-
con causes probe/target duplexes to dissociate and the
amount of fluorescence emission to decrease. Sequences
differing by as little as a single nucleotide may be detected
and differentiated on the basis of melting peak Tm. Fur-
thermore, multiple polymorphisms may be analysed
using a single probe, enabling the presence of additional
polymorphisms flanking PRNP codons 136, 141, 154 and
171 to be detected through distinct shifts in probe Tm.
The analysis of extracted DNA and unpurified sheep
blood samples is described here.
Methods
HyBeacon probes
The probes employed for the analysis of PRNP polymor-
phisms were synthesised by ATDBio Ltd (Southampton,
UK) and were each labelled using two fluorescein dT
monomers (Glen Research, Virginia, USA). Polymor-
phisms within codons 136, 154, 171 and 141 were inves-
tigated using the dual-labelled HyBeacons detailed in
table 1.
DNA extraction from sheep blood samples
8918 purified DNA samples were analysed using the
HyBeacon method, comparing 136, 154 and 171 codon
data with homogeneous MassEXTEND™ (hME) and
MALDI-ToF (Sequenom, Hamburg, Germany) results
obtained from the same sample set. The 141C3 probe was
evaluated using a further 400 DNA samples, again com-
paring genotype calls with MALDI-ToF data. EDTA-blood
samples were aspirated from sealed vacutainers (BD,BMC Infectious Diseases 2007, 7:90 http://www.biomedcentral.com/1471-2334/7/90
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Oxford, UK), transferring 50μl to 96 square well blocks
(QIAGEN, Crawley, UK) using a Tecan Genesis RSP 150
robot (Tecan, Berkshire, UK). Blood samples were trans-
ferred to 91 plate wells, leaving 5 wells available for posi-
tive and negative controls. DNA extraction was performed
using a Chemagen Chemagic magnetic separation mod-
ule I robot and Chemagic DNA Blood100 kits (Auto Q
Biosciences, Berkshire, UK), eluting DNA into 250μl of
tissue culture water (Sigma Aldrich, UK) in 96 low-well
plates.
Analysis of unpurified blood samples
3663 unpurified blood samples were analysed using the
HyBeacon methodology, comparing genotype calls with
hME and MALDI-ToF data obtained from extracted DNA
samples. 9μl of each blood sample was diluted in 710μl of
tissue culture water using 96 deep well plates and a Tecan
Genesis RSP 150 robot. Blood samples were transferred to
91 plate wells, leaving 5 wells available for positive and
negative controls. Samples were mixed for 10 minutes
using a Grant-bio PMS-1000 microplate shaker (Fisher
Scientific, Leicestershire, UK).
Polymerase Chain Reaction
PCR reaction volumes were 5μl, containing 1μl of purified
DNA or diluted blood sample, 1× QIAGEN PCR buffer,
0.05μM forward primer, 0.5μM reverse primer (table 1),
0.25 units HotStarTaq polymerase (QIAGEN, Crawley,
UK), 3 mM total MgCl2, 1 mM dNTPs (GE Healthcare,
Amersham, UK) and 100 nM of HyBeacon probe. Asym-
metric PCR was employed to generate an excess of the tar-
get strand such that probe hybridisation was favoured
over annealing of amplified sequences. Four 96 well
plates of extracted DNA or diluted bloods were analysed
simultaneously. 500× PCR mastermixes were prepared
such that sufficient reagents were available for robotic
preparation of 384 well PCR plates. A Hamilton LabSTAR
robot (Hamilton, Birmingham, UK) was employed to add
10μl of Chill-Out liquid wax (Bio-Rad Laboratories Ltd,
Hertfordshire, UK), 4μl of PCR mastermix and 1μl of sam-
ple to Microseal white 384 well PCR plates (Bio-Rad).
Each 384 well PCR plate contained 4 negative controls
and 16 extracted DNA controls of known genotype (ARH/
ARH, ARQ/ARH, ARR/ARH, VRQ/ARR, AHQ/AHQ, VRQ/
ARH, ARH/AHQ, VRQ/AHQ, ARR/AHQ, VRQ/ARQ,
ARQ/AHQ, ARR/ARR, ARQ/ARQ, ARR/ARQ & 2× VRQ/
VRQ). Each PCR mastermix contained a single HyBeacon
probe, such that three 384 well plates were employed to
analyse SNPs in codons 136, 154 and 171.
Amplification of target sequences was performed using a
384 well Tetrad thermal cycler (MJ Research). The 136F2
and 171R2 primers detailed in table 1 were employed to
amplify a PRNP target sequence of 198 bp, comprising
codons 119 through to 185. Following an initial denatur-
ation to activate the hotstart enzyme (95°C 15 minutes),
targets were amplified using 35 cycles (or 40 cycles for
diluted blood samples) comprising denaturation (95°C
15 seconds), primer annealing (55°C 30 seconds) and
extension of products (72°C 30 seconds). Following
amplification, reactions were incubated at 72°C for 2
minutes prior to a denaturation (95°C 1 minute) and
cool (20°C 10 minutes).
Melting curve analysis
PCR plates were heated from 35°C to 75°C, at 0.1°C per
second, using a LightTyper instrument (Roche Diagnos-
tics, Lewes, UK). Fluorescence emission was monitored
continuously to measure the stability of probe hybridisa-
tion and determine the identity of amplified target
sequences. Melting peaks were constructed by plotting the
negative derivative of fluorescence with respect to temper-
ature (-d(Fluorescence)/dT) on the y-axis) against temper-
ature (x-axis). Samples were genotyped with the
LightTyper software version 1.5 using positive control
samples to define peak standards. Peak Tm and area data
was exported from LightTyper software version 1.1 to gen-
erate an independent genotype call.
Determination of PRNP genotype using HyBeacon 
melting peaks
Samples were genotyped using a combination of LightTy-
per software calls and exported peak data. The LightTyper
software typically assigned genotypes to more than 95%
of samples based on a set of defined standards employing
reference control samples. Less than 5% of samples, for
Table 1: Primer and probe sequences employed for PRNP analysis
Primer/Probe Sequence (5'-3')
136F2 forward primer GCAGCTGGAGCAGTGGTAGG





F and 3 represent fluorescein dT and 3' phosphate respectively. Common SNPs within codons 136, 141, 154 and 171 are underlined. 5 represents 
the universal base 5-nitroindol employed to neutralise polymorphisms within codons 143 and 175.BMC Infectious Diseases 2007, 7:90 http://www.biomedcentral.com/1471-2334/7/90
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which the genotype was obvious by eye, required manual
analysis when the LightTyper software assigned weak pos-
itive or unknown calls due to minor variations of melt
curves from defined standards. A second, independent
genotype call was obtained by exporting peak data into a
Microsoft Excel spreadsheet that employed a combination
of peak Tms and areas to genotype samples. Peak area
ratios were employed to identify heterozygous samples
that potentially possessed more than two copies of the
PRNP gene [22,23]. A sample genotype was only reported
if LightTyper/manual calls were concordant with exported
spreadsheet data. Genotypes and rare sequence variants
are presented using the notation described by Goldmann
et al. [18].
Genotypes generated in HyBeacon tests were compared
with hME and MALDI-TOF analysis performed in parallel.
The hME assay employs MassEXTEND primers that
anneal to target sequences adjacent to the polymorphism
of interest. DNA polymerase is employed with a mixture
of nucleotides and terminators to extend from the primer
and through the polymorphic site. The resultant mass of
the primer extension product is determined by mass spec-
trometry and is used to determine the sequence of nucle-
otides at the polymorphic site [16].
Melting curve analysis with complementary 
oligonucleotides
The affect of rare polymorphisms on probe Tm was pre-
dicted using complementary oligonucleotides. 100 nM of
each probe was hybridised to 200 nM of oligonucleotide
homologue in QIAGEN PCR buffer and a total of 3 mM
MgCl2. Microseal white 384 well PCR plates (Bio-Rad)
were heated to 95°C for 1 minute and cooled to 20°C for
1 minute, prior to melting curve analysis using a LightTy-
per instrument, heating samples from 35°C to 75°C, at
0.1°C per second. Peak Tm data was determined using
LightTyper software version 1.1.
Results
Amplified targets were reliably detected and identified
using the Tms of HyBeacon melting peaks. Probes exhib-
ited ΔTms greater than 5°C, enabling reliable detection
and differentiation of A136, V136, L141, F141 R154, H154, R171,
Q171 and H171 melting peaks using the LightTyper soft-
ware. Samples that were homozygous at a given codon
yielded a single peak, of defined Tm, whereas hetero-
zygous samples yielded two melting peaks with character-
istic heights and areas. The mean Tms observed for each
probe peak are detailed in table 2. The major PRNP alleles
were typically identified if peak Tms deviated from
expected values by less than ± 2°C. The acceptance criteria
employed for the detection and identification of Q171
melting peaks were narrower than the mean Tm ± 2°C
due to the neighbouring L168 polymorphism. In each case,
the acceptance criteria for the major PRNP  alleles
exceeded the mean ± 3 standard deviations, ensuring
robust detection of melting peaks. Sequencing was per-
formed for samples that yielded unexpected peak Tms or
discordant HyBeacon/MALDI genotype calls. The detec-
tion of additional polymorphisms (e.g. T137 and L168) was
achieved if observed peak Tms deviated from expected
mean Tms (table 2) by at least 1.9°C.
Codon 136
The C to T polymorphism in codon 136 (Ala [A]>Val [V];
GCC>GTC) was analysed using the HyBeacon 136A2,
which possesses a C nucleotide at the polymorphic site.
The probe generated a melting peak with a Tm of approx-
imately 62.0°C when hybridised to the fully complemen-
tary alanine target sequence and exhibited a Tm of
approximately 53.2°C when hybridised to the mis-
matched valine target sequence (Fig 1A). Samples that
were heterozygous for A136  and V136  generated both
62.0°C and 53.2°C peaks (Fig. 1B).
A further T to C polymorphism within codon 137 (Met
[M]>Thr [T]; ATG>ACG), with a frequency in the UK flock
of approximately 0.012 [18], caused the 136A2 probe to
generate a peak Tm of approximately 59.5°C (Fig. 1A).
Samples possessing threonine at codon 137 were geno-
typed correctly and the polymorphism may either be
included (e.g. AT137RQ/VRQ) or omitted (e.g. ARQ/VRQ)
from reported genotypes. The presence of T137 in 3 of the
8918 DNA samples was confirmed through sequencing.
An additional SNP within codon 136 is responsible for
encoding threonine (Ala [A]>Thr [T]; GCC>ACC). The G
to A polymorphism causes the 136A2 probe to exhibit a
Tm of 56.9°C (Fig. 1B). This T allele has not been reported
in studies of UK flocks [18], but has been detected in other
countries [6]. Identification of the T136 melting peak was
demonstrated using Cypriot sheep samples of ARQ/TRQ
and TRQ/TRQ genotype. Differentiation of V136 and T136
peaks was demonstrated using a mixture of VRQ/VRQ and
TRQ/TRQ DNA samples. The 136A2 HyBeacon was dem-
onstrated to be capable of simultaneously analysing at
least three SNPs, generating four distinct melting peaks
(table 2).
Codon 154
The G to A polymorphism of codon 154 (Arg [R]>His [H];
CGT>CAT) was analysed using the HyBeacon 154H2,
which possesses an A nucleotide at the polymorphic site.
The probe generated melting peaks possessing an average
Tm of 56.6°C when hybridised to the fully complemen-
tary histidine target sequence and exhibited a C/A mis-
match and a Tm of approximately 49.9°C when
hybridised to the arginine target sequence. Samples thatBMC Infectious Diseases 2007, 7:90 http://www.biomedcentral.com/1471-2334/7/90
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were heterozygous for R154  and H154  generated both
56.6°C and 49.9°C peaks.
Codon 171
Two adjacent SNPs present in codon 171 are responsible
for encoding glutamine (CAG), arginine (CGG) and histi-
dine (CAT). The two SNPs were simultaneously analysed
using the HyBeacon 171R6, which yielded a peak Tm of
approximately 55.4°C when hybridised to the fully com-
plementary arginine codon. The probe exhibits single and
double nucleotide mismatches when hybridised to
glutamine and histidine sequence variants, reducing the
Tm of hybridisation to approximately 49.8°C and 44.8°C
respectively (table 2). Homozygous samples yielded sin-
gle melting peaks and heterozygous samples generated
two of the above peaks.
A rare SNP within codon 175 (Gln [Q]>Glu [E];
CAG>GAG) caused an earlier developmental version of
the 171 HyBeacon to miscall ARR/ARQE175 samples as
ARR/ARH. This SNP has a reported frequency in the UK
flock of 0.007 [18]. The E175 allele reduced the Tm of the
Q171 peak such that it fell within the acceptance range of
the H171 peak. To prevent such miscalls during analysis,
the polymorphism within codon 175 was neutralised
using the universal base 5-nitroindole, which is a syn-
thetic nucleotide analogue that hybridises equally with
the four naturally occurring bases [24]. The 171R6 HyBea-
con is unaffected by the E175 SNP (table 2) and generates
similar melting peaks with ARR/ARQ and ARR/ARQE175
samples. An additional probe may be designed if analysis
of E175 is required.
A further SNP within codon 168 (Pro [P]>Leu [L];
CCA>CTA), with a reported frequency of 0.008 in the UK
flock [18], was identified using the 171R6 HyBeacon. The
C to T polymorphism within codon 168 was reliably iden-
tified through shifts in peak melting temperature, for
example causing the Tm of the glutamine peak to be
reduced to approximately 48°C. The L168 polymorphism
was detected in 17 purified DNA samples and 4 of the
unpurified bloods. Samples possessing the L168 SNP were
genotyped correctly, confirmed by sequencing, and the
polymorphism may either be included (e.g. ARR/
ARL168Q) or omitted (e.g. ARR/ARQ) from reported gen-
otypes.
An additional SNP within codon 171 is responsible for
encoding lysine (Gln [Q]>Lys [K]; CAG>AAG). The 171R6
probe exhibits two nucleotide mismatches when hybrid-
ised to the lysine allele, generating a Tm of approximately
41°C. This K allele has not been reported in studies of UK
flocks [18], but has been detected in other countries [5].
Identification of the K171 melting peak was demonstrated
using Cypriot sheep samples of ARR/ARK, ARQ/ARK and
ARK/ARK genotype. Differentiation of H171 and K171 peaks
was demonstrated using a mixture of ARH/ARH and ARK/
ARK DNA samples.
The 171R6 HyBeacon is capable of simultaneously analys-
ing four SNPs, generating five distinct peaks.
Imbalanced melting peaks
Each parent sheep typically contributes a single PRNP
allele to its progeny, such that maternally and paternally
Table 2: Probe Tms and acceptance criteria
Probe Melting peak Mean Tm SD N Tm Acceptance 
Criteria
136A2 A136 62.0°C 0.49 2228 60.0°C – 64.0°C
136A2 V136 53.2°C 0.36 214 51.2°C – 55.2°C
136A2 T136 56.9°C 0.15 8 55.2°C – 58.9°C
136A2 AT137 59.5°C 0.19 7 59.0°C – 60.0°C
154H2 H154 56.6°C 0.51 300 54.6°C – 58.7°C
154H2 R154 49.9°C 0.29 2171 47.9°C – 51.9°C
171R6 R171 55.4°C 0.39 1524 53.4°C – 57.4°C
171R6 Q171 49.8°C 0.31 1392 48.4°C – 51.8°C
171R6 QE175 49.7°C 0.21 12 48.4°C – 51.8°C
171R6 L168Q 47.9°C 0.19 5 46.9°C – 48.4°C
171R6 H171 44.8°C 0.27 168 42.8°C – 46.8°C
171R6 K171 41.0°C 0.15 8 39.0°C – 42.8°C
141C3 F141 53.9°C 0.19 39 51.9°C – 55.9°C
141C3 L141 45.0°C 0.14 6 43.0°C – 47.0°C
The mean Tms for each probe melting peak are presented, where N is the number of peaks investigated and SD is the standard deviation. The peak 
Tms for the major PRNP alleles were obtained from six 384 well plates prepared on different working days, thereby accounting for sample-to-
sample and run-to-run sources of variation. Variant alleles exhibiting uncommon genotypes or additional SNPs are italicised. Acceptance criteria for 
these rare polymorphisms were estimated from the few samples analysed, minimising the potential for miscalling melting peaks.BMC Infectious Diseases 2007, 7:90 http://www.biomedcentral.com/1471-2334/7/90
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inherited alleles exist in a 1:1 ratio in 'normal' genotypes.
However, a small subset of sheep have been found to
exhibit abnormal (also known as complex) genotypes,
where the two alleles of heterozygous samples appear to
be present in unequal ratios [22,23]. Fluorescent primer
extension, hME/MALDI-ToF and HyBeacon analyses have
all yielded imbalanced peak data when analysing blood
samples. The generation of imbalanced peak data may
derive from a recognised genetic phenomenon known as
chimerism or could be caused by the presence of addi-
tional polymorphisms in target sequences. Analyses
employing alternate sample types, such as hair roots, ear
tissue plugs and saliva, are expected to resolve a large pro-
portion of the abnormal results obtained from blood.
Samples that yielded imbalanced melting peak data were
called "Unknown" by the LightTyper software. Melting
peaks were also determined to be imbalanced by measur-
ing the ratio between mismatched and matched peak
areas. Acceptance criteria for normal, balanced, heterozy-
gotes were determined using the area ratios obtained from
4560 purified DNA samples (i.e. twelve 384 well plates,
excluding negative controls). Acceptance criteria for peak
area ratios (table 3) were determined using only A136/V136,
R154/H154, R171/Q171, R171/H171 and Q171/H171 genotypes,
excluding data generated in the presence of additional
rare polymorphisms (e.g. R171/L168Q171). Samples that
exhibit imbalanced melting peaks and area ratios that are
outside of defined limits must be repeated for confirma-
tion.
The estimated frequency of animals appearing to possess
more than two copies of the PRNP gene is approximately
0.001 of the UK flock when analysing blood samples
[22,23]. Our study of 8918 purified DNA samples was
enriched for samples that had previously generated imbal-
anced peak data in MALDI-ToF analyses. Whilst 72 sam-
ples exhibited imbalanced MALDI peaks, only 43
heterozygous samples yielded imbalanced melting peaks.
Assay performance
The performance of HyBeacon PRNP assays was assessed
through determination of first time pass rates (FTPR) and
concordance with parallel homogeneous MassEXTEND™
and MALDI-ToF analysis. Samples that contributed to the
FTPR generated high quality peak data in 136, 154 and
171 assays. Samples were treated as "fails" if melting
peaks were absent from any one of the tests or if software/
analyst genotype calls were discordant with exported
spreadsheet data. Samples were also excluded from FTPR
Table 3: Peak area ratios and imbalanced melting peaks
Heterozygote Mean area ratio SD N Lower limit Upper limit
136 A/V 0.83 0.07 238 0.62 1.04
154 R/H 0.61 0.06 396 0.43 0.79
171 R/Q 0.97 0.08 1516 0.73 1.21
171 R/H 0.52 0.08 153 0.28 0.76
171 Q/H 0.75 0.06 46 0.57 0.93
4560 purified DNA samples were employed to determine the acceptance criteria for peak area ratios. The peak area ratios of heterozygous 
samples were calculated by dividing the area under the mismatched melting peak by the area under the matched melting peak. N is the number of 
heterozygous samples and SD is the standard deviation. Acceptance criteria for normal balanced heterozygotes were determined as the mean area 
ratio ± 3 standard deviations. Samples exhibiting imbalanced melting peaks generated area ratios outside of defined limits.
Detection of additional polymorphisms with the 136 HyBea- con Figure 1
Detection of additional polymorphisms with the 136 
HyBeacon. (A) The T137 polymorphism is detected as a 
melting peak at approximately 59.5°C and is clearly distinct 
from the A136 and V136 peaks at 62.0°C and 53.2°C respec-
tively. (B) T136 is detected as a melting peak at approximately 
56.9°C, enabling clear differentiation of genotypes such as 
ARR/VRQ and ARR/TRQ.BMC Infectious Diseases 2007, 7:90 http://www.biomedcentral.com/1471-2334/7/90
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if they exhibited imbalanced melting peaks. The average
FTPR for 384 well plates was 97.8% (standard deviation =
1.23) with purified DNA samples.
HyBeacon and MALDI-ToF genotype calls were 99.8%
concordant. The 17 DNA samples that yielded incongru-
ent calls were sequenced and confirmed to possess leucine
at codon 168, generating ARR/ARL168Q and ARL168Q/
ARH genotypes in HyBeacon tests. These samples yielded
imbalanced peaks in MALDI analyses and were reported
as ARR/ARR/ARQ and ARQ/ARH/ARH respectively [22].
Direct blood analysis
HyBeacon assays may also be performed directly using
unpurified sheep blood samples. Blood samples only
need to be diluted in water to reduce PCR inhibition and
lighten sample colour enabling fluorescence detection.
Five additional PCR cycles were required to analyse unpu-
rified blood samples due to the low DNA concentrations
once diluted. High quality melting peaks were obtained in
136, 154 and 171 assays, enabling accurate determination
of sample genotypes. Analyses employing unpurified
blood samples were extremely efficient yielding high
quality melting peaks with the majority of samples, dem-
onstrating first time pass rates between 85% and 95%
(mean = 91.2%). Pass rates using unpurified blood were
considerably more variable (standard deviation = 3.95)
than PCR plates employing purified DNA samples.
HyBeacon and MALDI-ToF data was 99.9% concordant,
where the 4 DNA samples that yielded incongruent calls
possessed leucine at codon 168. Blood samples yielded
elevated numbers of weak positives with melting peaks of
reduced height. Our study of 3663 unpurified blood sam-
ples was not enriched for samples that had previously gen-
erated imbalanced peak data in MALDI-ToF analyses.
Whilst 7 samples yielded imbalanced MALDI peaks (with
extracted DNA), 153 heterozygous samples exhibited
imbalanced melting peaks in at least one assay.
Predicting the affect of rare sequence variants
In addition to the T136, T137, L168, K171 and E175 polymor-
phisms described above, additional published polymor-
phisms in codons 138, 151, 154, 170 and 172 are covered
by the diagnostic probes [14,18]. The affect of glycine at
codon 170 (D170G; GAT>GGT) was investigated using
two DNA samples previously genotyped as ARR/AHG170Q
using a combination of hME, MALDI-ToF and sequencing
analysis. The G170 polymorphism reduced the Tm of the
171R6 melting peak to 40.0°C and is not expected to
compromise the accuracy of PRNP  genotypes. In the
absence of suitable DNA samples, the affects of other rare
polymorphisms were predicted by hybridisation of
probes to complementary oligonucleotide sequences
(table 4). Whilst melting peak Tms obtained with oligo-
nucleotide and PCR targets are expected to vary (e.g. due
to length and concentration differences), probe hybridisa-
tion to 200 nM of oligonucleotide homologue yielded
melting temperatures that were comparable with PCR
amplified target sequences.
Codon 141
A polymorphism within codon 141 has been linked to
atypical scrapie [8,9,18]. Codon 141 falls outside the
range of 136, 154 and 171 HyBeacons, so an additional
probe was designed to analyse this common polymor-
phism. The C to T polymorphism of codon 141 (Leu
[L]>Phe [F]; CTT>TTT) was analysed using the HyBeacon
141C3 (table 1), which possesses a C nucleotide at the
polymorphic site. Melting curve studies with complemen-
tary oligonucleotides predicted that asparagine at codon
138 would be reliably detected along with L141 and F141 in
all homozygous and heterozygous allele combinations
(table 4). In contrast the R143 polymorphism was pre-
dicted to cause L141R143 alleles to be miscalled as F141. The
R143 polymorphism was therefore neutralised using the
universal base 5-nitroindole as described above. Analysis
of codon 141 was performed using the same primers
employed for 136, 154 and 171 assays. The 141 HyBea-
con generated a melting peak possessing a Tm of approx-
imately 54°C when hybridised to the fully
complementary leucine target sequence and exhibited a
C/A mismatch and a Tm of approximately 44.5°C when
hybridised to the phenylalanine target sequence. Samples
that were heterozygous for L141 and F141 generated both
54°C and 44.5°C peaks. Sample genotypes were unaf-
fected by the presence of arginine at codon 143, with
HyBeacon and MALDI-ToF results in complete concord-
ance.
Discussion
The accuracy, reproducibility and robustness of HyBeacon
assays was evaluated using in excess of 8900 purified DNA
samples, comparing genotype calls with parallel homoge-
neous MassEXTEND™ and MALDI-ToF analysis. Samples
were analysed in 384 well plates using a LightTyper instru-
ment, achieving an average first time pass rate (FTPR) of
97.8%. HyBeacon and MALDI-ToF genotype calls were
99.8% concordant, where all discordant samples were
sequenced and confirmed to possess leucine at codon
168. Fewer samples yielded imbalanced peak data in
HyBeacon tests compared with hME and MALDI-ToF
analysis of the same sample set, thereby reducing the
number of samples requiring reanalysis.
Genotyping technologies that employ primer extension
events to characterise downstream SNPs (e.g. SNaPshot,
Applied Biosystems or hME, Sequenom) can be affected
by the presence of additional polymorphisms within the
primer sequences. Additional polymorphisms neighbour-
ing the SNPs of interest can considerably reduce the stabil-BMC Infectious Diseases 2007, 7:90 http://www.biomedcentral.com/1471-2334/7/90
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ity of genotyping primers and affect the efficiency of
extension, resulting in imbalanced peaks or allele drop-
out and potentially incorrect calls. The presence of leucine
at codon 168 reduces the efficiency of primer extension
with L168Q alleles in Sequenom hME assays, creating
MALDI peak imbalances in ARR/ARL168Q and ARL168Q/
ARH heterozygotes. L168 is detected using HyBeacons as a
decrease in Tm, such that Q and L168Q targets may be reli-
ably differentiated.
Alternate fluorescent probe technologies (such as hydrol-
ysis probes), which rely on real-time fluorescence
increases to detect and differentiate polymorphic
sequences, will also be affected by the presence of addi-
tional SNPs in target sequences. Such real-time PCR tech-
nologies typically employ a separate probe for each
sequence variant and would require seven probes just to
analyse the common 136, 154 and 171 alleles [25]. The
presence of additional SNPs within target sequences
would decrease the stability of real-time probes, reducing
or preventing the generation of fluorescent signal and
potentially generating incorrect genotypes. The stability of
HyBeacon hybridisation is also affected by the presence of
rare polymorphisms. However, unlike the genotyping
technologies described above, these additional SNPs are
detected through decreases in peak Tm, generating novel
melting peaks and correct calls. Post-amplification melt-
ing curve analysis of PRNP polymorphisms has also been
presented for HybProbes that employ fluorescence reso-
nance energy transfer (FRET) [26,27].
HyBeacon assays were able to detect the additional poly-
morphisms T136, T137 L168 and K171 through distinct shifts
in melting peak Tm. The rare polymorphisms R138, N138,
C151, H151, G151, L154 and D172 [14,18], were not encoun-
tered during validation of the HyBeacon assays, but their
effects were predicted using complementary oligonucle-
otide targets (table 4). R138, N138, H151, L154 and G170 are
not expected to affect the accuracy of PRNP genotype calls
since they result in melting peak Tms that are outside of
the acceptance criteria established for A136, V136, R154,
H154, R171, Q171 and H171 (table 2). C151, G151 and D172
polymorphisms are also expected to return the correct
PRNP  genotypes except when present in AHC151Q,
AHG151Q, ARRD172, ARQD172, AHQD172 and VRQD172
alleles, of which only C151 has been reported in the UK
flock (at a frequency of 0.002) [18]. Further unpublished
sequence polymorphisms could also give rise to incorrect
Table 4: Predicted Tms of rare PRNP polymorphisms
Probe Polymorphisms Oligonucleotide sequence (5'-3') Mean Tm SD
136A2 A136 GCCTGCTCATGGCACTTCCC 61.6°C 0.13
136A2 V136 GCCTGCTCATGACACTTCCC 53.3°C 0.13
136A2 A136 & S138R GCCTGCGCATGGCACTTCCC 57.3°C 0
136A2 V136 & S138R GCCTGCGCATGACACTTCCC 47.3°C 0.13
136A2 A136 & S138N GCCTGTTCATGGCACTTCCC 55.9°C 0.13
136A2 V136 & S138N GCCTGTTCATGACACTTCCC 44.9°C 0.18
154H2 H154 CATGTTTTCATGATAGTAACGGTC 57.2°C 0.18
154H2 R154 CATGTTTTCACGATAGTAACGGTC 50.2°C 0.18
154H2 H154 & R151C CATGTTTTCATGATAGTAACAGTC 51.4°C 0
154H2 R154 & R151C CATGTTTTCACGATAGTAACAGTC 43.1°C 0
154H2 H154 & R151H CATGTTTTCATGATAGTAATGGTC 52.7°C 0.13
154H2 R154 & R151H CATGTTTTCACGATAGTAATGGTC 45.2°C 0.13
154H2 H154 & R151G CATGTTTTCATGATAGTAACCGTC 51.1°C 0
154H2 R154 & R151G CATGTTTTCACGATAGTAACCGTC 42.8°C 0
154H2 R154L CATGTTTTCAAGATAGTAACGGTC 52.2°C 0.18
171R6 R171 TTCTGGTTACTATACCGATCCACTG 56.9°C 0
171R6 Q171 TTCTGGTTACTATACTGATCCACTG 50.5°C 0.27
171R6 H171 TTCTGGTTACTATAATGATCCACTG 45.2°C 0.18
171R6 R171 & Y172D TTCTGGTTACTATCCCGATCCACTG 50.5°C 0.28
171R6 Q171 & Y172D TTCTGGTTACTATCCTGATCCACTG 46.3°C 0.13
171R6 H171 & Y172D TTCTGGTTACTATCATGATCCACTG 40.7°C 0.13
141C3 L141 CCAAAATGTATAAGAGGCCTGCTC 54.1°C 0.17
141C3 F141 CCAAAATGTATAAAAGGCCTGCTC 45.1°C 0.13
141C3 L141 & S138N CCAAAATGTATAAGAGGCCTGTTC 49.4°C 0.13
141C3 F141 & S138N CCAAAATGTATAAAAGGCCTGTTC 39.2°C 0.17
141C3 L141 & H143R CCAAAACGTATAAGAGGCCTGCTC 54.9°C 0.13
141C3 F141 & H143R CCAAAACGTATAAAAGGCCTGCTC 45.6°C 0.13
Complementary oligonucleotides were employed to predict the affect of rare polymorphisms on probe melting temperature. Six replicate analyses 
were performed for each target oligonucleotide. The mean Tm and standard deviation (SD) for melting peaks is presented. The nucleotides 
representing the polymorphisms in codons 136, 141, 154 and 171 are highlighted along with rare polymorphisms in neighbouring codons.BMC Infectious Diseases 2007, 7:90 http://www.biomedcentral.com/1471-2334/7/90
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genotype calls if they result in melting peaks that coincide
with the expected Tms detailed in table 2. Several of the
other reported polymorphisms, such as S167 and K176 fall
outside the HyBeacon binding sites and have no effect on
peak Tms.
All genotyping technologies have the potential to miscall
PRNP genotypes when certain rare sequence variants are
present in primer/probe sequences. These miscalls may
remain undetected unless all samples are sequenced or
genotypes compared with an independent genotyping
method. Undesirable polymorphisms, which have the
potential to generate incorrect calls, may be neutralised
using universal nucleosides such as inosine, 3-nitropyr-
role and 5-nitroindole [24], as described here with R143
and E175. Alternatively, degenerative bases such as dP and
dK phosphoramidites may be introduced into oligonucle-
otides to base pair with A and G or with C and T respec-
tively (Glen Research, Virginia, USA). A more cost
effective method to "mask" additional polymorphisms
might be to design probe sequences such that they com-
prise a mismatched nucleotide at the polymorphic site
when hybridised to all possible target alleles [28]. The Tm
for each sequence variant should ideally differ by less than
1°C to ensure detection of further polymorphisms that
may flank the masked position.
The 136, 141, 154 and 171 assays were performed in sep-
arate PCR plates, each containing a single HyBeacon
probe. The HyBeacon assays were not combined into mul-
tiplexes to ensure that additional SNPs and imbalanced
melting peaks were reliably detected. The bottle-neck for
analysis within our laboratory was the number of PCR
plates that could be prepared per day. However, with two
Hamilton LabSTAR robots in operation up to 1440 sam-
ples could be analysed each day using 136, 154 and 171
assays. Furthermore, since each of the HyBeacon tests
employs the same primer pair, a single PCR plate can be
prepared for each batch of samples, without inclusion of
probes or Chill-Out liquid wax. Daughter plates prepared
robotically post-amplification will mix a portion of the
target amplicon with a specific HyBeacon probe. This
approach considerably increases the number of samples
that may be analysed each day. Melting curve analysis
using a LightCycler 480 instrument (Roche Diagnostics)
or similar real time PCR system would negate the require-
ment for Chill-Out liquid wax. The LightCycler 480
instrument will also permit colour-multiplexing with 384
well plates, enabling multiple probes labelled with spec-
trally distinct dyes to be employed simultaneously in each
well [19,27]. HyBeacon assays may be performed in both
high-throughput and ultra-rapid formats, where assays
performed in glass capillaries using a LightCycler instru-
ment are completed within 30 minutes.
The accuracy, reproducibility and robustness of blood
assays was evaluated using in excess of 3600 unpurified
samples. Whilst the average pass rate was in excess of
90%, the increased analysis times and repeat rates
required for direct blood analyses negate much of the cost
savings achieved through omitting DNA extraction. Fur-
ther development is required to enable unpurified blood
samples to be analysed in a high-throughput scenario.
However, "pen-side" tests could be performed using
unpurified blood samples and a portable PCR instrument.
Conclusion
The fluorescent probe assays described here provide an
extremely accurate and robust method for the analysis of
single and clustered PRNP gene polymorphisms. Target
sequences were detected through the generation of melt-
ing peaks and differentiated on the basis of melting tem-
perature. Genotyping assays were successfully validated
through comparison with a MALDI-ToF method and DNA
sequencing. The flexibility of the diagnostic tests enabled
samples to be correctly genotyped in the presence of addi-
tional sequence variations flanking the polymorphisms of
interest.
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